Compare Humana Inc (HUM) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Xpeng Inc - ADR — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Xpeng Inc - ADR trades at $11.76 (market cap $11.49B). The key difference: Humana Inc is far larger — about 4× Xpeng Inc - ADR's market cap, and Humana Inc pays a 0.92% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| HUM | XPEV | |
|---|---|---|
Market Cap | $46.31B | $11.49B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $28.07 |
52-Week Low | $163.67 | $11.68 |
Enterprise Value | $53.67B | $13.62B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
XPeng (XPEV) trades at $12.13, up 3.85% in the last session, with a bearish technical signal from moving averages but oversold RSI levels. The company reported revenue of $76.72 billion in 2025, with narrowing losses and a negative net income margin of -3.06%. Recent news highlights expansion into robotics and autonomous vehicles, with July 2026 deliveries up 4% year-over-year (PRNewsWire, August 1, 2026).
The outlook is mixed: analyst consensus is bullish with a $17.00 price target (64.7% buy ratings), but risks include persistent losses, high debt-to-asset ratio of 13.63 (2025), and intense EV competition. Upside potential hinges on new model launches and global growth, while cash flow volatility and macroeconomic pressures pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
